- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 160
Propzy prepares $25m series B round
GS Shop-backed real estate marketplace Propzy is seeking $25m to fund the launch of new services and enter new geographical markets.
Aug 13, 2019Clobotics clubs investors together to raise $22m
Wangsu-backed computer vision technology developer Clobotics has received pre-series B financing to extend its overall funding to at least $48m.
Aug 13, 2019Tastytrade coughs up $20m for Dough
Investment brokerage app developer has Dough received $20m from financial intelligence group and parent company Tastytrade ahead of a planned launch next month.
Aug 12, 2019WSC Sports wins $23m
Ofer Global, NTT Docomo, Harris Blitzer Sports & Entertainment, Intel and Go4It all signed up to a round that brought sports content management platform WSC's total funding to $39m.
Aug 12, 2019Glycomine glides to $33m series B round
The orphan disease drug developer's latest round was led by Novo while Asahi Kasei and Chiesi Ventures also participated, taking its overall funding to $46m.
Aug 9, 2019Cloudleaf collects $26m series B funding
Exiting investor Mahindra Partners contributed to an Intel Capital-led round that increased the industrial internet-of-things technology developer's total funding to $39m.
Aug 9, 2019Glycomine digs up $33m series B
Mission Bay Capital has backed a series B round for orphan diseases drug developer Glycomine, which also attracted Novo, Asahi Kasei Pharma and Chiesi.
Aug 9, 2019Experian credits CompareAsiaGroup in $20m round
Experian led a sereis B1 round for the Alibaba and SBI Group-backed Southeast Asia-focused financial comparison platform to take its total funding to about $115m.
Aug 8, 2019Sagimet settles series E at $25m
3-V Biosciences has changed its name to Sagimet Biosciences after closing a series E round backed by strategic partner Ascletis at $25m.
Aug 7, 2019IVX Health invites McKesson to latest round
Existing investor McKesson Ventures co-led the $22.5m round, which will enable IVX Health to open additional infusion and injection therapies centres.
Aug 7, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


